ZIOPHARM Oncology downgraded by Raymond James with a new price target
$ZIOP
Biotechnology: Pharmaceutical Preparations
Health Care
Raymond James downgraded ZIOPHARM Oncology from Outperform to Market Perform and set a new price target of $3.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/9/2021 | $3.00 → $2.00 | Market Perform | Raymond James |
| 8/10/2021 | Outperform → Mkt Perform | Raymond James | |
| 8/10/2021 | $3.00 | Outperform → Market Perform | Raymond James |